(Q41103564)

English

Nitric oxide-mediated neuronal injury in multiple sclerosis

scientific article published on October 1992

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

26 September 2017

Nitric oxide-mediated neuronal injury in multiple sclerosis (English)

1 reference

stated in

Europe PubMed Central

26 September 2017

0 references

3

Ignarro LJ

1 reference

stated in

Europe PubMed Central

26 September 2017

Sherman MP

1

1 reference

stated in

Europe PubMed Central

PubMed ID

1461176

retrieved

26 September 2017

Griscavage JM

series ordinal

2

1 reference

stated in

Europe PubMed Central

26 September 2017

1 October 1992

1 reference

stated in

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

39

1 reference

stated in

Europe PubMed Central

26 September 2017

143-146

1 reference

stated in

Europe PubMed Central

26 September 2017

2

1 reference

stated in

Europe PubMed Central

26 September 2017

Biosynthesis and metabolism of endothelium-derived nitric oxide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

T-cell-mediated activation of macrophages

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

MS: a CNS and systemic autoimmune disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Clinical viral infections and multiple sclerosis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Role of nitric oxide synthesis in macrophage antimicrobial activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Tnf-mediated cytotoxicity. importance of intracellular cgmp level for determining tnf-sensitivity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

The use of protease inhibitors in experimental allergic neuritis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0306-9877(92)90175-C

Identifiers

DOI

10.1016/0306-9877(92)90175-C

1 reference

stated in

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

PubMed ID

1461176

retrieved

26 September 2017

(Q41103564)

Nitric oxide-mediated neuronal injury in multiple sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)